These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


139 related items for PubMed ID: 6763115

  • 1. [Usefulness of the antimycogram in the treatment of vaginal mycosis].
    Stozek K, Wójcik J, Pawlik B.
    Med Dosw Mikrobiol; 1982; 34(3-4):177-84. PubMed ID: 6763115
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of candidal vaginitis with miconazole, a new broad-spectrum antimycotic. Changes in microbiology, vaginal pH and cytology.
    Peeters F, Snauwaert R, Segers J, Van Cutsem J, Amery W.
    Arzneimittelforschung; 1973 Aug; 23(8):1107-11. PubMed ID: 4588098
    [No Abstract] [Full Text] [Related]

  • 3. [Diagnostic and clinical characteristics of mycotic vaginitis caused by Candida glabrata (Torulopsis glabrata)].
    Pawlik B, Liber Z, Warzyńska R.
    Med Dosw Mikrobiol; 1989 Aug; 41(3-4):206-14. PubMed ID: 2701236
    [Abstract] [Full Text] [Related]

  • 4. [Evaluation of the antifungal effect of a new propiconazole derivative against 64 yeast strains isolated from vaginal mycosis].
    Mareş M, Stefanache A, Popovici I, Valica V, Buiuc D.
    Rev Med Chir Soc Med Nat Iasi; 2007 Aug; 111(3):768-72. PubMed ID: 18293715
    [Abstract] [Full Text] [Related]

  • 5. [Identification of yeast and sensitivity in vitro against different antifungal agents].
    Muriel MA, Vizcaíno MJ, Bilbao R, Herruzo R.
    Enferm Infecc Microbiol Clin; 2000 Mar; 18(3):120-4. PubMed ID: 10905013
    [Abstract] [Full Text] [Related]

  • 6. [Resistance against Candida is a current problem].
    Osterlund A, Strand A.
    Lakartidningen; 1998 Oct 07; 95(41):4476-7. PubMed ID: 9803739
    [No Abstract] [Full Text] [Related]

  • 7. [Evaluation of the results of laboratory-controlled treatment of vaginal mycoses].
    Prosiecki R, Bogaczewicz A, Pawlik B.
    Pol Tyg Lek; 1984 Mar 26; 39(13):433-6. PubMed ID: 6540874
    [No Abstract] [Full Text] [Related]

  • 8. [Routine application of serologic typing and in vitro tests of antifungal activity in vaginal mycosis].
    Perini M, Tampieri M, Rota G.
    Quad Sclavo Diagn; 1983 Dec 26; 19(4):463-71. PubMed ID: 6677939
    [Abstract] [Full Text] [Related]

  • 9. [Deep vaginal mycosis--a diagnostically and therapeutically re- fractory disease].
    Spitzbart H.
    Zentralbl Gynakol; 1988 Dec 26; 110(22):1455-6. PubMed ID: 3223120
    [Abstract] [Full Text] [Related]

  • 10. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Sobel JD, Ohmit SE, Schuman P, Klein RS, Mayer K, Duerr A, Vazquez JA, Rampalo A, HIV Epidemiology Research Study (HERS) Group.
    J Infect Dis; 2001 Jan 15; 183(2):286-93. PubMed ID: 11204125
    [Abstract] [Full Text] [Related]

  • 11. [Difficulties in the treatment of the vaginal mycosis].
    Spitzbart H.
    Mykosen; 1968 Sep 01; 11(9):617-8. PubMed ID: 5758268
    [No Abstract] [Full Text] [Related]

  • 12. [Nizoral - an effective and affordable drug to treat vaginal candidiasis ].
    Nikolov A.
    Akush Ginekol (Sofiia); 2009 Sep 01; 48 Suppl 1():44-7. PubMed ID: 20387276
    [No Abstract] [Full Text] [Related]

  • 13. [Frequency and antifungal profile of Candida isolated from vaginal exudates of preadolescent girls].
    Giusiano G, Rojas F, Toma-Vanacore S, Mangiaterra M.
    Enferm Infecc Microbiol Clin; 2009 Sep 01; 27(7):428. PubMed ID: 19403204
    [No Abstract] [Full Text] [Related]

  • 14. Vulvovaginal candidiasis in a Flemish patient population.
    De Vos MM, Cuenca-Estrella M, Boekhout T, Theelen B, Matthijs N, Bauters T, Nailis H, Dhont MA, Rodriguez-Tudela JL, Nelis HJ.
    Clin Microbiol Infect; 2005 Dec 01; 11(12):1005-11. PubMed ID: 16307555
    [Abstract] [Full Text] [Related]

  • 15. [Clotrimazole (Canesten) in the treatment of vulvar mycosis].
    Wojcik J, Stozek K, Pawlik B.
    Ginekol Pol; 1982 Dec 01; 53(5-6):453-8. PubMed ID: 6761239
    [No Abstract] [Full Text] [Related]

  • 16. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006.
    Fan SR, Liu XP, Li JW.
    J Obstet Gynaecol Res; 2008 Aug 01; 34(4):561-6. PubMed ID: 18937710
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of vaginal candidiasis in pregnant women with primaricine].
    Bret AJ, Crimail P.
    Rev Fr Gynecol Obstet; 1965 Jun 01; 60(6):463-75. PubMed ID: 5319870
    [No Abstract] [Full Text] [Related]

  • 18. In vitro miconazole susceptibility and clinical outcome in vulvovaginal candidiasis.
    Fan SR, Liu XP.
    Int J Gynaecol Obstet; 2007 Jun 01; 97(3):207-8. PubMed ID: 17462651
    [No Abstract] [Full Text] [Related]

  • 19. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
    Saporiti AM, Gómez D, Levalle S, Galeano M, Davel G, Vivot W, Rodero L.
    Rev Argent Microbiol; 2001 Jun 01; 33(4):217-22. PubMed ID: 11833253
    [Abstract] [Full Text] [Related]

  • 20. Letter: Vaginal candidosis.
    Br Med J; 1976 Jun 19; 1(6024):1528-9. PubMed ID: 1276751
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.